Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand

EU orphan designation number: EU/3/18/2085   
Active ingredient: Autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand
Indication: Treatment of pancreatic cancer
Sponsor: Rigenerand S.r.l.
Via Maestri del Lavoro, n.4, 41036 Medolla (MO), Italia

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2018 Orphan designation EMA/OD/110/18 (2018)7794 of 19/11/2018